William Lavery, MD
Allergy & Immunology · Overland Park, KSNPI 1457779605
Payments from drug & device makers
Across 310 payments — averaging $54,408 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Swedish Orphan Biovitrum AB$9.1M
- Mylan Pharmaceuticals Inc.$4.7M
- Deciphera Pharmaceuticals Inc.$1.8M
- E.r. Squibb & Sons, L.L.C.$876K
- Modernatx, Inc.$190K
- GSK$101K
- plus $40K from 24 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Swedish Orphan Biovitrum AB | 15 | $9,142,779 |
| Mylan Pharmaceuticals Inc. | 6 | $4,684,493 |
| Deciphera Pharmaceuticals Inc. | 18 | $1,832,220 |
| E.r. Squibb & Sons, L.L.C. | 1 | $876,282 |
| Modernatx, Inc. | 28 | $189,841 |
| GSK | 42 | $100,805 |
| Teva Pharmaceuticals USA, Inc. | 10 | $14,855 |
| AstraZeneca | 35 | $11,869 |
| Genentech USA, Inc. | 15 | $9,521 |
| Sanofi | 44 | $1,808 |
| Regeneron Healthcare Solutions, Inc. | 40 | $861 |
| Takeda Pharmaceuticals U.S.A., Inc. | 13 | $244 |
| Biocryst US Sales Co., LLC | 7 | $146 |
| Pfizer | 4 | $113 |
| Amgen | 5 | $93 |
| Grifols USA, LLC | 3 | $60 |
| Hospira, Inc. | 4 | $56 |
| AbbVie | 2 | $52 |
| CSL Behring | 2 | $49 |
| Pharming Healthcare, Inc. | 3 | $47 |
| LEO Pharma Inc. | 2 | $42 |
| Novartis | 2 | $36 |
| Kaleo, Inc. | 2 | $35 |
| Grifols Shared Services North America, Inc. | 1 | $31 |
| Boehringer Ingelheim | 1 | $24 |
| Optinose US, Inc. | 1 | $23 |
| Blueprint Medicines Corporation | 1 | $22 |
| Regeneron | 1 | $20 |
| ADMA Biomanufacturing LLC | 1 | $18 |
| Merck | 1 | $16 |
How this compares
$16,866,461 in reported general payments places this provider in the 95th percentile of 33 allergy & immunology providers in Kansas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other allergy & immunology in Overland Park
- Derrick WardOverland Park$2.9M
- Henry KanarekOverland Park$740K
- Celina BernabeOverland Park$95K
- James SternerOverland Park$92K
- Jeffrey WaldOverland Park$86K
- Mark NeustromOverland Park$82K
- Sara AzzamOverland Park$19K
- Nguyen TranOverland Park$15K
- Cori PasserOverland Park$14K
- H LevineOverland Park$3K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.